Synchrocast: Understanding Brexit and its Impact on Patients

Synchrogenix's Darshan Kulkarni, Vice President, Regulatory Strategy and Policy, and Nirpal Virdee, Director, Client Services and Technology, talk about Brexit and its impact on patients. Listen in (or read the transcript) to learn more about Brexit, including the reasons behind the binary public referendum put to the United Kingdom's citizens back in 2016, and the outcome of the voting results. After providing thorough Brexit background, Darshan and Nirpal dive into Brexit's impact on the pharmaceutical industry and patients.

Synchrocast podcast button

Listen to the Synchrocast

Synchrocast transcript icon

Download the transcript


Click here to learn more about Synchrogenix’s regulatory and communications technology, services and solutions.


Leave a Comment